"Comparing 0.1% Ropivacaine and 0.0625% Bupivacaine, with fentanyl for labour pain relief"
Phase 1
Not yet recruiting
- Conditions
- Obstetrics,
- Registration Number
- CTRI/2019/05/019271
- Lead Sponsor
- G Ranganaayaki
- Brief Summary
With the help of this study, we would like to identify the drug which is safe and long acting with less adverse effects to be used as a labour analgesia. I would like to implicate findings of this study so as to provide adequate analgesia during labour. We would like to compare between 0.1% Ropivacaine and 0.0625% Bupivacaine in releiving labour pain with less or no adverse effects, duration of action of each drug.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Female
- Target Recruitment
- 40
Inclusion Criteria
- Parturients requesting epidural analgesia in SMVMCH from May 2019 to September 2020 2.
- Parturients of ASA physical status 1 and 2 3.Parturients in active labour with cervical dilation of more than 3 cm 4.
- Full term live fetus without any obstetric complication.
Exclusion Criteria
- 1)Height < 150cm 2)BMI >30 3)Age <18 years 4)Anticipated difficult intubation 5)Contraindications for epidural catheter placement 6)Hyper-sensitivity to study drugs.
- 7)Administration of IV analgesics within 1hr of epidural request.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain relief Visual analog scale score will be recorded every 5 min for first 30 min, then at every 30 min till the end of labor. VAS at the end of the first stage and second stage is also noted.
- Secondary Outcome Measures
Name Time Method maternal sedation sensory blockade
Trial Locations
- Locations (1)
Sri ManakulaVinayagar Medical College and Hospital
🇮🇳Pondicherry, PONDICHERRY, India
Sri ManakulaVinayagar Medical College and Hospital🇮🇳Pondicherry, PONDICHERRY, IndiaG RanganaayakiPrincipal investigator9789709095rangaganesan@gmail.com